Feedback
BIOCON 
Reputation: 642,729 • Feb 16, 2023 5:18 PM
Biocon reports a consolidated net loss of Rs 42 crore in Q3. Here’s what analysts say
A one-time loss of Rs 271 crore during the quarter, mainly owing to professional fees paid for the acquisition of the global biosimilars business of American company Viatris, triggered the loss
Moneycontrol
Vote
Comment
Share
NSE:BIOCON price when posted: 245.05